Crestline Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-66,492
| Closed | -$1.88M | – | 218 |
|
|
2018
Q2 | $1.88M | Buy |
66,492
+35,453
| +114% | +$1M | 0.2% | 148 |
|
|
2018
Q1 | $1.1M | Sell |
31,039
-7,381
| -19% | -$261K | 0.14% | 139 |
|
|
2017
Q4 | $1.49M | Buy |
38,420
+5,516
| +17% | +$214K | 0.15% | 60 |
|
|
2017
Q3 | $836K | Sell |
32,904
-14,265
| -30% | -$362K | 0.12% | 108 |
|
|
2017
Q2 | $1.29M | Buy |
+47,169
| New | +$1.29M | 0.17% | 67 |
|